A drug design strategy based on molecular docking and molecular dynamics simulations applied to development of inhibitor against triple-negative breast cancer by Scutellarein derivatives.

Triple-negative breast cancer (TNBC), accounting for 10-15% of all breast malignancies, is more prevalent in women under 40, particularly in those of African descent or carrying the BRCA1 mutation. TNBC is characterized by the absence of estrogen and progesterone receptors (ER, PR) and low or elevat...

Full description

Bibliographic Details
Main Authors:	Shopnil Akash, Farjana Islam Aovi, Md A K Azad, Ajoy Kumer, Unesco Chakma, Md Rezaul Islam, Nobendu Mukerjee, Md Mominur Rahman, Imren Bayıl, Summya Rashid, Rohit Sharma
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2023-01-01
Series:	PLoS ONE
Online Access:	https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0283271&type=printable

Internet

https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0283271&type=printable

A drug design strategy based on molecular docking and molecular dynamics simulations applied to development of inhibitor against triple-negative breast cancer by Scutellarein derivatives.

Internet

Similar Items